Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1997 Jul-Aug;70(4):391–402.

The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.

R Bruck 1, R Hershkoviz 1, O Lider 1, H Shirin 1, H Aeed 1, Z Halpern 1
PMCID: PMC2589337  PMID: 9626759

Abstract

In chronic viral hepatitis, autoimmune hepatitis, and some chronic cholestatic liver diseases, T-lymphocytes serve as effector cells of the immunostimulatory processes. Cellular interactions of immune cells with extracellular matrix (ECM) components are regulated primarily via the beta 1 subfamily of integrin receptors. The target epitope of several such integrin receptors is the Arg-Gly-Asp (RGD) sequence, a cell adhesion motif shared by several matrix-associated adhesive glycoproteins. We review the use of synthetic nonpeptidic analogues of RGD and of soluble receptor of tumor necrosis factor (TNF)-alpha in the prevention of immune-mediated, concanavalin A-induced liver damage in mice and of RGD analogues in inhibiting the development of liver cirrhosis in rats. The concanavalin A-induced elevation of serum transaminases and TNF-alpha, and the infiltration of liver tissue by inflammatory cells, were inhibited by pretreatment of the mice with the synthetic RGD mimetics and soluble TNF receptor. In rats, the progression of thioacetamide-induced liver cirrhosis was markedly inhibited by the coadministration of the RGD mimetic SF-6,5. The compounds described here may be examined therapeutically for pathological conditions in the liver, manifested as necroinflammation, cholestasis and fibrosis.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes J. L., Hastings R. R., De la Garza M. A. Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol. 1994 Sep;145(3):585–597. [PMC free article] [PubMed] [Google Scholar]
  2. Bonadonna G. From adjuvant to neo-adjuvant chemotherapy in high-risk breast cancer: the experience of the Milan Cancer Institute. Steiner Award Lecture 1992. Int J Cancer. 1993 Aug 19;55(1):1–4. doi: 10.1002/ijc.2910550102. [DOI] [PubMed] [Google Scholar]
  3. Brown L. F., Dubin D., Lavigne L., Logan B., Dvorak H. F., Van de Water L. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol. 1993 Mar;142(3):793–801. [PMC free article] [PubMed] [Google Scholar]
  4. Bruck R., Hershkoviz R., Lider O., Aeed H., Zaidel L., Matas Z., Barg J., Halpern Z. Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope. J Hepatol. 1996 Jun;24(6):731–738. doi: 10.1016/s0168-8278(96)80270-4. [DOI] [PubMed] [Google Scholar]
  5. Bruck R., Shirin H., Hershkoviz R., Lider O., Kenet G., Aeed H., Matas Z., Zaidel L., Halpern Z. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice. Gut. 1997 Jan;40(1):133–138. doi: 10.1136/gut.40.1.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Casini A., Pinzani M., Milani S., Grappone C., Galli G., Jezequel A. M., Schuppan D., Rotella C. M., Surrenti C. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology. 1993 Jul;105(1):245–253. doi: 10.1016/0016-5085(93)90033-9. [DOI] [PubMed] [Google Scholar]
  7. Chevallier M., Guerret S., Chossegros P., Gerard F., Grimaud J. A. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology. 1994 Aug;20(2):349–355. [PubMed] [Google Scholar]
  8. Czaja M. J., Weiner F. R., Flanders K. C., Giambrone M. A., Wind R., Biempica L., Zern M. A. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol. 1989 Jun;108(6):2477–2482. doi: 10.1083/jcb.108.6.2477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. D'Souza S. E., Ginsberg M. H., Plow E. F. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends Biochem Sci. 1991 Jul;16(7):246–250. doi: 10.1016/0968-0004(91)90096-e. [DOI] [PubMed] [Google Scholar]
  10. Ferguson T. A., Mizutani H., Kupper T. S. Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8072–8076. doi: 10.1073/pnas.88.18.8072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Friedman S. L., Roll F. J., Boyles J., Arenson D. M., Bissell D. M. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem. 1989 Jun 25;264(18):10756–10762. [PubMed] [Google Scholar]
  12. Gantner F., Leist M., Lohse A. W., Germann P. G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 1995 Jan;21(1):190–198. doi: 10.1016/0270-9139(95)90428-x. [DOI] [PubMed] [Google Scholar]
  13. Greenspoon N., Hershkoviz R., Alon R., Varon D., Shenkman B., Marx G., Federman S., Kapustina G., Lider O. Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence. Biochemistry. 1993 Feb 2;32(4):1001–1008. doi: 10.1021/bi00055a002. [DOI] [PubMed] [Google Scholar]
  14. Hershkoviz R., Alon R., Gilat D., Lider O. Activated T lymphocytes and macrophages secrete fibronectin which strongly supports cell adhesion. Cell Immunol. 1992 May;141(2):352–361. doi: 10.1016/0008-8749(92)90154-h. [DOI] [PubMed] [Google Scholar]
  15. Hershkoviz R., Gilat D., Miron S., Mekori Y. A., Aderka D., Wallach D., Vlodavsky I., Cohen I. R., Lider O. Extracellular matrix induces tumour necrosis factor-alpha secretion by an interaction between resting rat CD4+ T cells and macrophages. Immunology. 1993 Jan;78(1):50–57. [PMC free article] [PubMed] [Google Scholar]
  16. Hershkoviz R., Greenspoon N., Mekori Y. A., Hadari R., Alon R., Kapustina G., Lider O. Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-Asp. Clin Exp Immunol. 1994 Feb;95(2):270–276. doi: 10.1111/j.1365-2249.1994.tb06522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hershkoviz R., Lider O., Bruck R., Aeed H., Greenspoon N., Halpern Z. Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope. J Hepatol. 1995 Feb;22(2):158–164. doi: 10.1016/0168-8278(95)80423-4. [DOI] [PubMed] [Google Scholar]
  18. Hershkoviz R., Melamed S., Greenspoon N., Lider O. Nonpeptidic analogues of the Arg-Gly-Asp (RGD) sequence specifically inhibit the adhesion of human tenon's capsule fibroblasts to fibronectin. Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2585–2591. [PubMed] [Google Scholar]
  19. Horn T., Junge J., Christoffersen P. Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J Hepatol. 1986;3(3):333–340. doi: 10.1016/s0168-8278(86)80486-x. [DOI] [PubMed] [Google Scholar]
  20. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  21. Kagami S., Border W. A., Ruoslahti E., Noble N. A. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest. 1993 Jul;69(1):68–76. [PubMed] [Google Scholar]
  22. Martinez-Hernandez A. The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis. Lab Invest. 1985 Aug;53(2):166–186. [PubMed] [Google Scholar]
  23. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., Satoh S., Niwa M., Senoh H., Fujiwara H. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med. 1994 May 1;179(5):1529–1537. doi: 10.1084/jem.179.5.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Müller A., Machnik F., Zimmermann T., Schubert H. Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model. Exp Pathol. 1988;34(4):229–236. doi: 10.1016/s0232-1513(88)80155-5. [DOI] [PubMed] [Google Scholar]
  25. Nuber R., Teutsch H. F., Sasse D. Metabolic zonation in thioacetamide-induced liver cirrhosis. Histochemistry. 1980;69(3):277–288. doi: 10.1007/BF00489773. [DOI] [PubMed] [Google Scholar]
  26. Pinzani M., Gesualdo L., Sabbah G. M., Abboud H. E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 1989 Dec;84(6):1786–1793. doi: 10.1172/JCI114363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Reid L. M., Fiorino A. S., Sigal S. H., Brill S., Holst P. A. Extracellular matrix gradients in the space of Disse: relevance to liver biology. Hepatology. 1992 Jun;15(6):1198–1203. doi: 10.1002/hep.1840150635. [DOI] [PubMed] [Google Scholar]
  28. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem. 1988;57:375–413. doi: 10.1146/annurev.bi.57.070188.002111. [DOI] [PubMed] [Google Scholar]
  29. Ruoslahti E. Integrins. J Clin Invest. 1991 Jan;87(1):1–5. doi: 10.1172/JCI114957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Salo T., Turpeenniemi-Hujanen T., Tryggvason K. Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J Biol Chem. 1985 Jul 15;260(14):8526–8531. [PubMed] [Google Scholar]
  31. Schiff E. R. Hepatic fibrosis--new therapeutic approaches. N Engl J Med. 1991 Apr 4;324(14):987–989. doi: 10.1056/NEJM199104043241409. [DOI] [PubMed] [Google Scholar]
  32. Shimizu Y., Van Seventer G. A., Horgan K. J., Shaw S. Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells. Nature. 1990 May 17;345(6272):250–253. doi: 10.1038/345250a0. [DOI] [PubMed] [Google Scholar]
  33. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  34. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992 Jul;90(1):196–203. doi: 10.1172/JCI115836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Watanabe Y., Morita M., Akaike T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology. 1996 Sep;24(3):702–710. doi: 10.1053/jhep.1996.v24.pm0008781346. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES